• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌细胞的直接重编程导致异常的癌症甲基组和转录组逆转。

Reversal of aberrant cancer methylome and transcriptome upon direct reprogramming of lung cancer cells.

机构信息

Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

出版信息

Sci Rep. 2012;2:592. doi: 10.1038/srep00592. Epub 2012 Aug 21.

DOI:10.1038/srep00592
PMID:22912920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3423637/
Abstract

Recent reports on direct reprogramming of cancer cells (iPCs) which results in reduced tumorigenic potential has attributed the importance of epigenetics in tumorigenesis, but lacked genome-wide analysis. Here we describe successful generation of iPCs from non-small cell lung cancer (NSCLC) cell lines. Following reprogramming, they resembled embryonic stem and induced pluripotent stem cells in pluripotency markers expression, gene expression patterns and in vitro differentiation ability. Genome-wide methylation analysis revealed that aberrantly methylated promoters which were mostly developmental-associated genes and tumor suppressors; as well as commonly upregulated genes in NSCLC i.e. KRT19 and S100P were reversed in iPCs upon reprogramming. Also, the reversal of oncogenes and tumor suppressors status were partially explainable by DNA methylation. These findings suggest that DNA methylation patterns explain the downstream transcriptional effects, which potentially caused the reduced tumorigenicity in iPCs, thus providing evidence that reprogramming reverses the aberrantly dysregulated genes in NSCLC both epigenetically and transcriptionally.

摘要

最近有研究报告称,通过直接重编程癌细胞(iPCs)可以降低肿瘤发生的潜力,这归因于表观遗传学在肿瘤发生中的重要性,但缺乏全基因组分析。在这里,我们描述了成功地从非小细胞肺癌(NSCLC)细胞系中生成 iPCs。在重编程后,它们在多能性标记物表达、基因表达模式和体外分化能力方面类似于胚胎干细胞和诱导多能干细胞。全基因组甲基化分析显示,异常甲基化的启动子主要是发育相关基因和肿瘤抑制基因;以及在 NSCLC 中普遍上调的基因,如 KRT19 和 S100P,在 iPCs 中重编程后被逆转。此外,癌基因和肿瘤抑制基因状态的逆转部分可以通过 DNA 甲基化来解释。这些发现表明,DNA 甲基化模式解释了下游转录效应,这可能导致 iPCs 中肿瘤发生性降低,从而提供了证据表明重编程在表观遗传和转录水平上逆转了 NSCLC 中异常失调的基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/d8df464e5f95/srep00592-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/eb0f27f0b1d2/srep00592-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/88a096069a6e/srep00592-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/13a397a25419/srep00592-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/f656f9ef887c/srep00592-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/8a7dd2d2c05a/srep00592-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/d8df464e5f95/srep00592-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/eb0f27f0b1d2/srep00592-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/88a096069a6e/srep00592-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/13a397a25419/srep00592-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/f656f9ef887c/srep00592-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/8a7dd2d2c05a/srep00592-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/563b/3423637/d8df464e5f95/srep00592-f6.jpg

相似文献

1
Reversal of aberrant cancer methylome and transcriptome upon direct reprogramming of lung cancer cells.肺癌细胞的直接重编程导致异常的癌症甲基组和转录组逆转。
Sci Rep. 2012;2:592. doi: 10.1038/srep00592. Epub 2012 Aug 21.
2
An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.肺癌的综合表观基因组-转录组图谱揭示了具有诊断和治疗意义的新型甲基化驱动基因。
Theranostics. 2021 Mar 11;11(11):5346-5364. doi: 10.7150/thno.58385. eCollection 2021.
3
Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.非小细胞肺癌患者的全基因组 CpG 岛甲基化分析。
Carcinogenesis. 2013 Mar;34(3):513-21. doi: 10.1093/carcin/bgs363. Epub 2012 Nov 19.
4
Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale.诱导人内皮细胞多能性在基因组范围内重置表观遗传特征。
Cell Cycle. 2010 Mar 1;9(5):937-46. doi: 10.4161/cc.9.5.10869. Epub 2010 Mar 6.
5
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.在非小细胞肺癌中被DNA甲基化抑制的基因揭示了上皮-间质转化的表观遗传学特征。
BMC Genomics. 2014 Dec 8;15(1):1079. doi: 10.1186/1471-2164-15-1079.
6
Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.CDH13 和 MGMT 基因启动子异常甲基化与原发性非小细胞肺癌的临床病理特征相关。
Clin Lung Cancer. 2012 Jul;13(4):297-303. doi: 10.1016/j.cllc.2011.11.003. Epub 2011 Dec 13.
7
Genome Wide Methylome Alterations in Lung Cancer.肺癌中的全基因组甲基化组改变
PLoS One. 2015 Dec 18;10(12):e0143826. doi: 10.1371/journal.pone.0143826. eCollection 2015.
8
Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.靶向组蛋白甲基转移酶 G9a 通过表观遗传调控非小细胞肺癌中 HP1α 和 APC2 基因的表达抑制生长和 Wnt 信号通路。
Mol Cancer. 2018 Oct 22;17(1):153. doi: 10.1186/s12943-018-0896-8.
9
Global analysis of CpG methylation reveals epigenetic control of the radiosensitivity in lung cancer cell lines.全球 CpG 甲基化分析揭示了肺癌细胞系放射敏感性的表观遗传控制。
Oncogene. 2010 Aug 19;29(33):4725-31. doi: 10.1038/onc.2010.223. Epub 2010 Jun 7.
10
Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.在早期肺腺癌中,候选肿瘤抑制因子TRIM58常因启动子甲基化而沉默。
Oncotarget. 2017 Jan 10;8(2):2890-2905. doi: 10.18632/oncotarget.13761.

引用本文的文献

1
Engineered immune cell therapies for solid tumors: pharmacological advances, clinical outcomes, and future directions.实体瘤的工程化免疫细胞疗法:药理学进展、临床结果及未来方向。
Front Pharmacol. 2025 Jun 12;16:1614325. doi: 10.3389/fphar.2025.1614325. eCollection 2025.
2
Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.可能的策略来降低重编程正常和癌细胞的致瘤风险。
Int J Mol Sci. 2024 May 9;25(10):5177. doi: 10.3390/ijms25105177.
3
Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors.

本文引用的文献

1
Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.肿瘤抑制基因ZAC/PLAGL1:嗜铬细胞瘤中印记非依赖等位基因的表达改变与缺失
Cancer Genet. 2011 Jul;204(7):398-404. doi: 10.1016/j.cancergen.2011.07.002.
2
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus.帕金森病诱导多能干细胞中α-突触核蛋白基因三重复。
Nat Commun. 2011 Aug 23;2:440. doi: 10.1038/ncomms1453.
3
DNA hypermethylation in lung cancer is targeted at differentiation-associated genes.
诱导多能干细胞在恶性实体肿瘤中的应用。
Stem Cell Rev Rep. 2023 Nov;19(8):2557-2575. doi: 10.1007/s12015-023-10633-y. Epub 2023 Sep 27.
4
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.串联各点:黑素瘤细胞起源、肿瘤细胞可塑性、转分化和耐药性。
Pigment Cell Melanoma Res. 2023 Sep;36(5):330-347. doi: 10.1111/pcmr.13092. Epub 2023 May 3.
5
Cancer cells as a new source of induced pluripotent stem cells.癌细胞作为诱导多能干细胞的新来源。
Stem Cell Res Ther. 2022 Sep 5;13(1):459. doi: 10.1186/s13287-022-03145-y.
6
Revisiting Epithelial Carcinogenesis.重新审视上皮性肿瘤发生。
Int J Mol Sci. 2022 Jul 4;23(13):7437. doi: 10.3390/ijms23137437.
7
Pluripotency Stemness and Cancer: More Questions than Answers.多能性 干性与癌症:问题多于答案。
Adv Exp Med Biol. 2022;1376:77-100. doi: 10.1007/5584_2021_663.
8
"Reprogram Enablement" as an Assay for Identifying Early Oncogenic Pathways by Their Ability to Allow Neoplastic Cells to Reacquire an Epiblast State.“重编程激活”作为一种通过肿瘤细胞重新获得上胚层状态的能力来鉴定早期致癌途径的检测方法。
Stem Cell Reports. 2020 Sep 8;15(3):761-775. doi: 10.1016/j.stemcr.2020.07.016. Epub 2020 Aug 13.
9
Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells.利用患者特异性诱导多能干细胞进行血液疾病和癌症建模。
Front Immunol. 2018 Sep 28;9:2243. doi: 10.3389/fimmu.2018.02243. eCollection 2018.
10
Application of induced pluripotency in cancer studies.诱导多能性在癌症研究中的应用。
Rep Pract Oncol Radiother. 2018 May-Jun;23(3):207-214. doi: 10.1016/j.rpor.2018.04.005. Epub 2018 Apr 24.
肺癌中的 DNA 高甲基化靶向分化相关基因。
Oncogene. 2012 Mar 1;31(9):1181-8. doi: 10.1038/onc.2011.307. Epub 2011 Aug 1.
4
HIF induces human embryonic stem cell markers in cancer cells.低氧诱导因子诱导癌细胞表达人类胚胎干细胞标志物。
Cancer Res. 2011 Jul 1;71(13):4640-52. doi: 10.1158/0008-5472.CAN-10-3320. Epub 2011 Jun 28.
5
Is carcinogenesis a form of speciation?致癌作用是物种形成的一种形式吗?
Cell Cycle. 2011 Jul 1;10(13):2100-14. doi: 10.4161/cc.10.13.16352.
6
Stat5: from breast development to cancer prognosis, prediction, and progression.信号转导及转录激活因子5:从乳腺发育到癌症预后、预测及进展
J Clin Oncol. 2011 Jun 20;29(18):2443-4. doi: 10.1200/JCO.2010.34.2014. Epub 2011 May 16.
7
CpG islands and the regulation of transcription.CpG 岛与转录调控。
Genes Dev. 2011 May 15;25(10):1010-22. doi: 10.1101/gad.2037511.
8
Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway.Id1 通过 Akt 相关途径促进肺癌细胞增殖和肿瘤生长。
Cancer Lett. 2011 Aug 28;307(2):191-9. doi: 10.1016/j.canlet.2011.04.003. Epub 2011 May 4.
9
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
10
Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.人类胚胎干细胞和诱导多能干细胞变异参考图谱可实现多能细胞系的高通量特征分析。
Cell. 2011 Feb 4;144(3):439-52. doi: 10.1016/j.cell.2010.12.032.